Mimedx (MDXG) EBT (2011 - 2026)

Mimedx (MDXG) has 16 years of EBT data on file, last reported at -$15.3 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 278.02% year-over-year to -$15.3 million; the trailing twelve-month figure through Mar 2026 stood at $42.3 million (down 22.34% YoY), and the FY2025 full-year result was $66.3 million, up 15.65% from the prior year.
• EBT declined to -$15.3 million in Q1 2026, from $21.8 million in the prior quarter.
• In the past five years, EBT ranged from a high of $23.2 million in Q2 2024 to a low of -$15.3 million in Q1 2026.
• A 5-year average of $7.0 million and a median of $9.9 million in 2022 frame the typical range for EBT.
• Peak annual rise in EBT reached 10732.97% in 2022, while the deepest fall reached 505.72% in 2022.
• Tracing MDXG's EBT over 5 years: stood at $9.9 million in 2022, then soared by 41.13% to $13.9 million in 2023, then declined by 19.15% to $11.2 million in 2024, then surged by 93.75% to $21.8 million in 2025, then tumbled by 170.34% to -$15.3 million in 2026.
• Business Quant data shows MDXG's EBT at -$15.3 million in Q1 2026, $21.8 million in Q4 2025, and $22.8 million in Q3 2025.